ONAR (OTCQB: ONAR), a marketing technology leader and agency network, has appointed veteran life sciences executive Howard Palefsky to its Board of Directors and named him Chair of the Governance and Nominating Committee. Palefsky brings decades of experience as a CEO, investor, and board member across healthcare, medtech, and capital markets, having contributed to over $4 billion in value creation through IPOs, M&A, and strategic growth initiatives worldwide.
CEO Claude Zdanow praised the appointment, citing Palefsky’s financial market acumen and healthcare background as key to advancing ONAR’s growth in the healthcare marketing space. Palefsky joins following a period of transformation at ONAR and will serve alongside recently added board member Jon Bond as the company continues scaling its M&A and agency network strategies. For more information, visit https://www.onar.com.
The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR. This appointment underscores ONAR's strategic focus on leveraging seasoned industry expertise to drive its expansion and enhance governance, positioning the company for sustained growth and value creation in the competitive marketing technology and healthcare sectors.
